2024-09-04 - Analysis Report
## CVS Health Corporation (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacies, pharmacy benefit management, and health services businesses. 

**1. Performance Comparison:**

* **Cumulative Return:** CVS has experienced a cumulative return of **-17.37%**, lagging significantly behind the S&P 500 (VOO) which has returned **89.66%**.
* **Relative I-Score:**  Currently, CVS is **107.03%** lower than the S&P 500. This indicates a significant underperformance compared to the benchmark index.

**2. Recent Price Movement:**

* **Closing Price:** $57.24
* **5-Day Moving Average:** $57.52
* **20-Day Moving Average:** $57.56
* **60-Day Moving Average:** $58.95

The stock is currently trading slightly below its recent moving averages, suggesting a possible short-term downward trend.

**3. Technical Indicators:**

* **RSI:** 59.78. This indicates a neutral to slightly overbought market condition.
* **PPO:** -0.05. A negative PPO suggests a potential bearish sentiment. 
* **Delta_Previous_Relative_Divergence:** -11.1. This indicates a short-term decline in relative performance.
* **Expected Return:** 12.6%. This represents the estimated maximum potential return on investment over the next five years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The latest earnings report for the quarter ending August 7th, 2024, showed an EPS of 1.83, exceeding the expected EPS of 1.73. This suggests a positive earnings performance. However, it's important to note that the EPS has been declining over the past few quarters, indicating a potential slowdown in earnings growth.

**5. Summary:**

CVS Health Corporation is currently underperforming the market, with its stock price significantly lagging behind the S&P 500. The recent price action suggests a possible short-term downward trend, supported by a slightly overbought RSI and a negative PPO. While the latest earnings report beat expectations, the declining trend in EPS over the past few quarters raises concerns about future earnings growth. 

**6. Conclusion:**

Despite the recent earnings beat, CVS's underperformance relative to the market and concerns about future earnings growth suggest a cautious approach to this stock. Investors should monitor the company's future earnings reports and overall market conditions before making any investment decisions. 
